Skip to main content

Fresenius Medical Care Reaches Analyst Target Price

In recent trading, shares of Fresenius Medical Care AG (FMS) have crossed above the average analyst 12-month target price of $22.50, changing hands for $22.81/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.